Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

61,435 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Addition of intraperitoneal cisplatin and etoposide to first-line chemotherapy for advanced ovarian cancer: a randomised, phase 2 trial.
Shi T, Jiang R, Yu J, Yang H, Tu D, Dai Z, Shen Y, Zhang Y, Cheng X, Jia H, Tu R, Wang H, Tang J, Luan Y, Cai S, Zang R; SGOG-OV/AICE Investigators. Shi T, et al. Among authors: yang h. Br J Cancer. 2018 Jul;119(1):12-18. doi: 10.1038/s41416-018-0036-7. Epub 2018 Jun 14. Br J Cancer. 2018. PMID: 29899395 Free PMC article. Clinical Trial.
Survival benefits of dose-dense early postoperative intraperitoneal chemotherapy in front-line therapy for advanced ovarian cancer: a randomised controlled study.
Shi T, Jiang R, Pu H, Yang H, Tu D, Dai Z, Cai Y, Zhang Y, Cheng X, Jia H, Tu R, Wang H, Tang J, Luan Y, Cai S, Zang R; SGOG-OV/AICE Investigators. Shi T, et al. Among authors: yang h. Br J Cancer. 2019 Aug;121(5):425-428. doi: 10.1038/s41416-019-0543-1. Epub 2019 Aug 6. Br J Cancer. 2019. PMID: 31383985 Free PMC article. Clinical Trial.
Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial.
Shi T, Zhu J, Feng Y, Tu D, Zhang Y, Zhang P, Jia H, Huang X, Cai Y, Yin S, Jiang R, Tian W, Gao W, Liu J, Yang H, Cheng X, Zang R. Shi T, et al. Among authors: yang h. Lancet Oncol. 2021 Apr;22(4):439-449. doi: 10.1016/S1470-2045(21)00006-1. Epub 2021 Mar 8. Lancet Oncol. 2021. PMID: 33705695 Clinical Trial.
Real-world outcomes of niraparib treatment in patients with ovarian cancer: a multicenter non-interventional study in China.
Li J, Yang J, Shou H, Zhang L, Huang X, Tang X, Zheng F, Liu F, Wen H, Yang H, Wang H, Li Z, Chen X, Ju X, Cheng X, Tang J, Zhang M, Wu X. Li J, et al. Among authors: yang h, yang j. Cancer Commun (Lond). 2023 Jun;43(6):716-719. doi: 10.1002/cac2.12418. Epub 2023 Apr 11. Cancer Commun (Lond). 2023. PMID: 37040265 Free PMC article. No abstract available.
61,435 results
You have reached the last available page of results. Please see the User Guide for more information.